1. Impact of caval vein implantation on severity of tricuspid regurgitation, renal and hepatic function in patients with severe secondary tricuspid regurgitation. (25th November 2020) Authors: Mattig, I; Hewing, B; Knebel, F; Stangl, V; Laule, M; Stangl, K; Dreger, H Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increased expression of inactive rhomboid protein 2 in circulating monocytes after acute myocardial infarction. (11th May 2021) Authors: Van Dijck, P; Hannemann, C; Dreger, H; Stangl, K; Ludwig, A; Hewing, B Journal: European journal of preventive cardiology Issue: Volume 28:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1488Treatment of severe tricuspid regurgitation in patients with advanced heart failure with caval vein implantation of the edwards sapien XT valve (TRICAVAL): a controlled prospective randomized trial. (28th August 2018) Authors: Laule, M; Mattig, I; Hewing, B; Schoebel, C; Knebel, F; Lauten, A; Lembcke, A; Thoenes, M; Baumann, G; Stangl, V; Landmesser, U; Stangl, K; Dreger, H Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗